Efficacy and Safety of the Fixed-Dose Combination of Atorvastatin/Fenofibrate Versus Atorvastatin on the Lipid Profile of Patients with Type 2 Diabetes and Dyslipidemia
Authors
Francisco G Padilla-Padilla
María M Arguedas-Núñez (ORCID: https://orcid.org/0000-0002-3301-2695)
Laura A. Lugo‐Sánchez (ORCID: https://orcid.org/0000-0003-1392-4512)
Juan A Peraza-Zaldívar (ORCID: https://orcid.org/0000-0002-4689-4404)
José G. Sander-Padilla (ORCID: https://orcid.org/0000-0002-4832-4624)
Efficacy and Safety of the Fixed-Dose Combination of Atorvastatin/Fenofibrate Versus Atorvastatin on the Lipid Profile of Patients with Type 2 Diabetes and Dyslipidemia
Francisco G Padilla-Padilla, María M Arguedas-Núñez, Laura A. Lugo‐Sánchez, Juan A Peraza-Zaldívar et al.
Journal
Cardiology and Therapy
Topics
Lipoproteins and Cardiovascular Health
article
Efficacy and Safety of the Fixed-Dose Combination of Atorvastatin/Fenofibrate Versus Atorvastatin on the Lipid Profile of Patients with Type 2 Diabetes and Dyslipidemia
Francisco G Padilla-Padilla, María M Arguedas-Núñez, Laura A. Lugo‐Sánchez, Juan A Peraza-Zaldívar, José G. Sander-Padilla, Jorge González‐Canudas, Luis Miguel Román-Pintos, KEVIN F. RIOS-BRITO, Diana Flores-Huanosta, Lina N Ruiz-Bernes
article en
Abstract
No abstract available for this paper.
Publication Tag
Cardiology and TherapyVol. 14(2)
Institutions
Universidad de Guadalajara (MX), Secretaría de Salud de Jalisco (MX), Universidad Chapultepec (MX), Hospital Civil de Guadalajara (MX), Centro de Investigación y Proyectos en Ambiente y Desarrollo (MX)